Breakthrough Tag Fast-Tracks Cancer Gambit

A personalized mRNA melanoma vaccine combined with Keytruda kept more patients cancer-free and cut the risk of the disease returning or spreading in major trials, according to the companies and independent reports. Story Highlights Merck and Moderna report their personalized mRNA melanoma vaccine improved outcomes when added to Keytruda. Trials show fewer recurrences and less […]